Monthly premiums for an average 2020 Obamacare health insurance plan will fall about 4 percent from 2019, according to a report released by the Trump administration.
U.S. President Donald Trump will unveil an executive order aimed at strengthening Medicare for seniors, seeking to improve the health program’s fiscal position and offer more affordable plan options, administration officials said.
U.S. federal agents executed a warrant to search the Clio Laboratories in Georgia as part of a nationwide crackdown into genetic testing fraud against federal health insurance programs.
Cognoa and Eversana announce partnership to advance commercialization standard for prescription digital medicines
Cognoa and Eversana announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by insurance.
Democratic presidential candidates disagree on the best path forward for health insurance coverage.
A proposed move to universal health coverage in South Africa will be rolled out in stages as the budget improves, a senior presidential aide told Reuters, forecasting the landmark reform would cost $2.2 billion per year by 2025/2026.
The Trump administration scrapped a proposal for lowering prescription medicine prices, backing down from a policy that would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to Medicare patients.
A federal appeals court panel expressed skepticism to Democratic calls to overturn the ruling of a Texas judge who found the landmark U.S. healthcare reform law unconstitutional.
A group of Democratic-led states and the House of Representatives urged a federal appeals court to overturn a Texas judge’s ruling that the U.S. healthcare reform law is unconstitutional.
Pfizer Did Not Pursue Possible Evidence of Enbrel Helping with Alzheimer’s Due to Low Chance of Clinical Success
In 2015, Pfizer researchers were analyzing hundreds of thousands of insurance claims and noted that patients receiving the company’s anti-inflammatory Enbrel appeared to have a reduced risk of Alzheimer’s disease – by a startling 64 percent.